EP1037669A4 - Emploi therapeutique de vecteurs lentiviraux - Google Patents

Emploi therapeutique de vecteurs lentiviraux

Info

Publication number
EP1037669A4
EP1037669A4 EP98962895A EP98962895A EP1037669A4 EP 1037669 A4 EP1037669 A4 EP 1037669A4 EP 98962895 A EP98962895 A EP 98962895A EP 98962895 A EP98962895 A EP 98962895A EP 1037669 A4 EP1037669 A4 EP 1037669A4
Authority
EP
European Patent Office
Prior art keywords
therapeutic use
lentiviral vectors
lentiviral
vectors
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98962895A
Other languages
German (de)
English (en)
Other versions
EP1037669A1 (fr
Inventor
Luigi Naldini
Jin-Ping Song
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cell Genesys Inc
Original Assignee
Cell Genesys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Genesys Inc filed Critical Cell Genesys Inc
Publication of EP1037669A1 publication Critical patent/EP1037669A1/fr
Publication of EP1037669A4 publication Critical patent/EP1037669A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
EP98962895A 1997-12-12 1998-12-11 Emploi therapeutique de vecteurs lentiviraux Withdrawn EP1037669A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6957997P 1997-12-12 1997-12-12
US69579P 1997-12-12
PCT/US1998/025720 WO1999030742A1 (fr) 1997-12-12 1998-12-11 Emploi therapeutique de vecteurs lentiviraux

Publications (2)

Publication Number Publication Date
EP1037669A1 EP1037669A1 (fr) 2000-09-27
EP1037669A4 true EP1037669A4 (fr) 2003-04-02

Family

ID=22089926

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98962895A Withdrawn EP1037669A4 (fr) 1997-12-12 1998-12-11 Emploi therapeutique de vecteurs lentiviraux

Country Status (6)

Country Link
EP (1) EP1037669A4 (fr)
JP (1) JP2002508338A (fr)
KR (1) KR20010033062A (fr)
AU (1) AU749059B2 (fr)
CA (1) CA2314683A1 (fr)
WO (1) WO1999030742A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4540033B2 (ja) 1999-10-22 2010-09-08 サノフィ パストゥール リミテッド 腫瘍抗原に対する免疫応答を誘発および／または増強する方法
US6656706B2 (en) 1999-12-23 2003-12-02 The United States Of America As Represented By The Department Of Health And Human Services Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
ATE513913T1 (de) 2000-05-10 2011-07-15 Sanofi Pasteur Ltd Durch mage minigene kodierte immunogene polypeptide und ihre verwendungen
US6712612B1 (en) 2000-12-12 2004-03-30 Genecure Llc Safe and stable retroviral helper cell line and related compositions and methods
WO2004060346A2 (fr) 2002-12-30 2004-07-22 Angiotech International Ag Liberation de medicaments a partir d'une composition polymere a gelification rapide
JP2006524051A (ja) 2003-04-24 2006-10-26 フォンダッチォーネ・セントロ・サン・ラファエル・デル・モンテ・タボール 両方向性合成プロモーターを備えたレンチウイルスベクターおよびその使用
US9593340B2 (en) 2007-10-15 2017-03-14 Admedus Vaccines Pty Ltd. Expression system for modulating an immune response
US9795658B2 (en) 2010-04-20 2017-10-24 Admedus Vaccines Pty Ltd Expression system for modulating an immune response
JP7110108B2 (ja) 2015-12-09 2022-08-01 ジンガン メディスン（オーストラリア） プロプライアタリー リミティド 治療用免疫調節組成物
WO2018018082A1 (fr) 2016-07-26 2018-02-01 The Australian National University Compositions immunostimulantes et utilisations de celles-ci

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996028565A1 (fr) * 1995-03-16 1996-09-19 Hisamitsu Pharmaceutical Co., Inc. Nouveau recombinant genique
WO1997012622A1 (fr) * 1995-10-06 1997-04-10 The Salk Institute For Biological Studies Vecteur et procede permettant d'alimenter en acide nucleique des cellules ne subissant pas de division
WO1997020060A1 (fr) * 1995-11-28 1997-06-05 The Johns Hopkins University School Of Medicine Replication conditionnelle de vecteurs viraux et leur utilisation
WO1997020052A1 (fr) * 1995-11-28 1997-06-05 Clinical Technologies, Inc. Vih recombine, cellules d'encapsidation modifiees et methode de traitement du syndrome d'immunodeficience acquise
WO1997031119A1 (fr) * 1996-02-21 1997-08-28 Res Inst For Genetic And Human Procedes et compositions pour l'immunisation genetique protectrice et therapeutique
WO1997032983A1 (fr) * 1996-03-05 1997-09-12 The Regents Of The University Of California Virus de l'immunodeficience feline vivants recombines et vaccins d'adn proviraux
WO1998003669A2 (fr) * 1996-07-22 1998-01-29 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Vecteurs d'administration d'inhibiteurs de cellules virales et oncogenes
WO1998039463A2 (fr) * 1997-03-06 1998-09-11 Ueberla Klaus Vecteur a base de lentivirus et systeme de vecteur
WO1998040493A1 (fr) * 1997-03-11 1998-09-17 The University Court Of The University Of Glasgow Vaccin anti-vif
WO1999004026A2 (fr) * 1997-07-18 1999-01-28 Chiron Corporation Vecteurs lentiviraux

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650309A (en) * 1995-05-16 1997-07-22 The Regents Of The University Of California Viral vectors

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996028565A1 (fr) * 1995-03-16 1996-09-19 Hisamitsu Pharmaceutical Co., Inc. Nouveau recombinant genique
WO1997012622A1 (fr) * 1995-10-06 1997-04-10 The Salk Institute For Biological Studies Vecteur et procede permettant d'alimenter en acide nucleique des cellules ne subissant pas de division
WO1997020060A1 (fr) * 1995-11-28 1997-06-05 The Johns Hopkins University School Of Medicine Replication conditionnelle de vecteurs viraux et leur utilisation
WO1997020052A1 (fr) * 1995-11-28 1997-06-05 Clinical Technologies, Inc. Vih recombine, cellules d'encapsidation modifiees et methode de traitement du syndrome d'immunodeficience acquise
WO1997031119A1 (fr) * 1996-02-21 1997-08-28 Res Inst For Genetic And Human Procedes et compositions pour l'immunisation genetique protectrice et therapeutique
WO1997032983A1 (fr) * 1996-03-05 1997-09-12 The Regents Of The University Of California Virus de l'immunodeficience feline vivants recombines et vaccins d'adn proviraux
WO1998003669A2 (fr) * 1996-07-22 1998-01-29 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Vecteurs d'administration d'inhibiteurs de cellules virales et oncogenes
WO1998039463A2 (fr) * 1997-03-06 1998-09-11 Ueberla Klaus Vecteur a base de lentivirus et systeme de vecteur
WO1998040493A1 (fr) * 1997-03-11 1998-09-17 The University Court Of The University Of Glasgow Vaccin anti-vif
WO1999004026A2 (fr) * 1997-07-18 1999-01-28 Chiron Corporation Vecteurs lentiviraux

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Derwent World Patents Index; AN 1996-433836, XP002229729 *
NALDINI L ET AL: "IN VIVO GENE DELIVERY AND STABLE TRANSDUCTION OF NONDIVIDING CELLS BY A LENTIVIRAL VECTOR", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 272, no. 5259, 12 April 1996 (1996-04-12), pages 263 - 267, XP000583652, ISSN: 0036-8075 *
POESCHLA E ET AL: "DEVELOPMENT OF HIV VECTORS FOR ANTI-HIV GENE THERAPY", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 93, no. 21, 15 October 1996 (1996-10-15), pages 11395 - 11399, XP000616290, ISSN: 0027-8424 *
See also references of WO9930742A1 *

Also Published As

Publication number Publication date
JP2002508338A (ja) 2002-03-19
AU749059B2 (en) 2002-06-20
WO1999030742A1 (fr) 1999-06-24
EP1037669A1 (fr) 2000-09-27
CA2314683A1 (fr) 1999-06-24
AU1803599A (en) 1999-07-05
KR20010033062A (ko) 2001-04-25

Similar Documents

Publication Publication Date Title
GB9708484D0 (en) Therapeutic agents
GB9708945D0 (en) Therapeutic agents
GB9704948D0 (en) Therapeutic agents
GB9702524D0 (en) Therapeutic agents
GB9711753D0 (en) Therapeutic agents
GB9713707D0 (en) Therapeutic agents
GB9711114D0 (en) Therapeutic agents
EP1037669A4 (fr) Emploi therapeutique de vecteurs lentiviraux
GB9702392D0 (en) Therapeutic agents
GB9620777D0 (en) Therapeutic use
GB9700555D0 (en) Therapeutic agents
GB9723999D0 (en) Therapeutic use
GB9726701D0 (en) Therapeutic use
GB9726702D0 (en) Therapeutic use
TW354896U (en) Improvement of bateering massager bat
TW325694U (en) Improved structure of physical therapeutic belt
GB9717260D0 (en) Therapeutic use
GB9721193D0 (en) Therapeutic use
GB9721221D0 (en) Therapeutic use
GB9721265D0 (en) Therapeutic use
GB9721194D0 (en) Therapeutic use
GB9721192D0 (en) Therapeutic use
GB9726699D0 (en) Therapeutic use
GB9708288D0 (en) Therapeutic use
GB9721191D0 (en) Therapeutic use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000628

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: CELL GENESYS, INC.

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SONG, JIN-PING

Inventor name: NALDINI, LUIGI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61P 31/18 B

Ipc: 7A 61P 31/14 B

Ipc: 7C 12N 15/86 B

Ipc: 7A 61K 48/00 A

A4 Supplementary search report drawn up and despatched

Effective date: 20030217

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: CELL GENESYS, INC.

17Q First examination report despatched

Effective date: 20040907

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060701